Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
0.1725
+0.0212 (14.01%)
At close: May 12, 2025, 4:00 PM
0.1650
-0.0075 (-4.35%)
After-hours: May 12, 2025, 7:59 PM EDT
VOR's stock price has decreased by -89.91% in the past year and price targets may not have had time to catch up.
Vor Biopharma Analyst Ratings
Total Analysts
7
Consensus Rating
Buy
Price Target
$7.83
Upside
+4,439.13%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy → Hold Downgrades $6 | Buy → Hold | Downgrades | $6 | +3,378.26% | May 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 9, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $8 | Buy | Reiterates | $8 | +4,537.68% | Mar 21, 2025 |
| Stifel | Stifel | Strong Buy Maintains $12 → $5 | Strong Buy | Maintains | $12 → $5 | +2,798.55% | Mar 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $13 | Strong Buy | Maintains | $18 → $13 | +7,436.23% | Mar 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +10,044.93% | Dec 10, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +6,856.52% | Dec 10, 2024 |
| Baird | Baird | Buy Maintains $22 → $14 | Buy | Maintains | $22 → $14 | +8,015.94% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +10,044.93% | Nov 8, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +6,856.52% | Sep 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +10,044.93% | Sep 6, 2024 |
| Barclays | Barclays | Buy Maintains $10 → $3 | Buy | Maintains | $10 → $3 | +1,639.13% | Aug 14, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $12 | Buy | Reiterates | $12 | +6,856.52% | May 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $15 → $10 | Buy | Reiterates | $15 → $10 | +5,697.10% | May 13, 2024 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +6,276.81% | May 10, 2024 |
| Wedbush | Wedbush | Buy Reiterates $11 | Buy | Reiterates | $11 | +6,276.81% | Apr 23, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.